Jan Pander
Impact in
- Dermatology top 5%
- Dermatology and Skin Diseases
-
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
- Oncology 4
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Henk‐Jan Guchelaar (8 shared papers)Hans A. J. Gelderblom (8 shared papers)Tahar van der Straaten (4 shared papers)Cornelis J.A. Punt (3 shared papers)Renée F. Baak-Pablo (1 shared paper)Hans Morreau (1 shared paper)Ninja F. Antonini (1 shared paper)Thorbald van Hall (1 shared paper)
- Journals
- Clinical Cancer Research (1 paper)Infectious Diseases and Therapy (1 paper)Clinical Kidney Journal (1 paper)Annals of Oncology (1 paper)Expert Opinion on Pharmacotherapy (1 paper)
- Partner nations
- NetherlandsFrance
In The Last Decade
Jan Pander
14 papers receiving 408 citations
Peers
Comparison fields: 5 of 58
- Dermatology 104
- Oncology 102
- Pharmacology 43
- Immunology 49
- Applied Microbiology and Biotechnology 3
Countries citing papers authored by Jan Pander
This map shows the geographic impact of Jan Pander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Pander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Pander more than expected).
Fields of papers citing papers by Jan Pander
This network shows the impact of papers produced by Jan Pander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Pander. The network helps show where Jan Pander may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Pander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 108 | |
| 2 | 2011 | 92 | |
| 3 | 2010 | 69 | |
| 4 | 2007 | 42 | |
| 5 | 2010 | 33 | |
| 6 | 2009 | 18 | |
| 7 | 2015 | 14 | |
| 8 | 2007 | 13 | |
| 9 | 2010 | 13 | |
| 10 | Pharmacogenetics of small-molecule tyrosine kinase inhibitors: Optimizing the magic bullet. | 2010 | 8 |
| 11 | 2025 | 3 | |
| 12 | 2023 | 2 | |
| 13 | 2024 | 2 | |
| 14 | 2025 | 2 |
About Jan Pander
Jan Pander is a scholar working on Pharmacology, Oncology, Dermatology, Health Information Management and Nephrology, having authored 14 papers that have together received 419 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Treatments and Mutations (1 paper), Dermatology and Skin Diseases (1 paper), COVID-19 Clinical Research Studies (1 paper), Immune cells in cancer (1 paper), Electronic Health Records Systems (1 paper) and Machine Learning in Healthcare (1 paper). The work is most often cited by research in Dermatology (104 citations), Oncology (102 citations), Pharmacology (43 citations), Immunology (49 citations) and Applied Microbiology and Biotechnology (3 citations). Jan Pander has collaborated with scholars based in Netherlands and France. Frequent co-authors include Henk‐Jan Guchelaar, Hans A. J. Gelderblom, Tahar van der Straaten, Cornelis J.A. Punt, Renée F. Baak-Pablo, Hans Morreau, Ninja F. Antonini, Thorbald van Hall, Ekaterina S. Jordanova and Moniek Heusinkveld. Their work appears in journals such as Clinical Cancer Research, Infectious Diseases and Therapy, Clinical Kidney Journal, Annals of Oncology and Expert Opinion on Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.